Merck KGaA (MKGAF)

Market Cap	63.08B
Revenue (ttm)	23.38B
Net Income (ttm)	3.01B
Shares Out	n/a
EPS (ttm)	6.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120
Open	145.15
Previous Close	145.07
Day's Range	142.05 - 145.15
52-Week Range	142.05 - 200.56
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1668
• Employees: 62,908
• Stock Exchange: OTCMKTS
• Ticker Symbol: MKGAF

Financial Performance

In 2023, Merck KGaA's revenue was 20.99 billion, a decrease of -5.57% compared to the previous year's 22.23 billion. Earnings were 2.82 billion, a decrease of -15.09%.

Financial numbers in EUR